Oncology

The latest from Cogstate, leaders in optimizing the measurement of cognition

Cogstate Brief Battery Shows Correlation With Traditional Tests of Cognition In Breast Cancer Population

May 1, 2017

As the complexity and geographic distribution of clinical trials increase, there is a growing need for more efficient cognitive testing of participants. Traditional “pencil and paper” neuropsychological tests have been the gold standard but require expert administration and manual data collection. To scale to hundreds of patients located around the world, computerized cognitive testing offers […]

Cogstate Computerized Battery Effective For Long-Term Monitoring of Cognitive Side Effects in Pediatric Leukemia Patients

October 20, 2016

Children with acute lymphoblastic leukemia (ALL) often battle neurocognitive deficits as a result of their radiation or chemotherapy treatment. During treatment and sometimes up to two years after treatment, their quality of life is affected by impairments in attention, processing speed and executive functioning. While many pediatric leukemia studies have identified possible counter measures later […]

Understanding Cognitive Decline In Breast Cancer Patients Treated With Endocrine Therapy

May 14, 2016

While there will be almost a quarter million new diagnoses of breast cancer this year in the U.S., the percentage of survivors has been on the rise since 1989. Treatment regimens that include chemotherapy and adjuvant endocrine therapies have been proven effective for hormone receptor positive patients. Specifically, two recent clinical trials, TEXT and Suppression […]

Cogstate iPad Cognitive Assessments Selected for Use In Phase IV Observational Study of Approved Treatments for Prostate Cancer

November 19, 2015

Cogstate Ltd (ASX: CGS), leaders in the measurement of cognition in clinical trials, is pleased to announce that their iPad-based computerized cognitive assessment technology has been selected for use in a multicenter Phase IV observational study to assess the tolerability of two approved drugs for the treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC). Supporting the […]

Children’s Oncology Group Relies On Cogstate For Pediatric Cognition Testing

January 3, 2014

When attacking a disease as diverse and complicated as cancer, it is critical to have an equally diverse but coordinated research collaborative working together. When the patient is a child, the urgency for a treatment or cure increases substantially.  This was the motivation for four pediatric oncology research groups to voluntarily join together back in […]